SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477037-21-000002
Filing Date
2021-03-04
Accepted
2021-03-04 19:02:43
Documents
1
Period of Report
2020-12-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4190
  Complete submission text file 0001477037-21-000002.txt   5667
Mailing Address C/O BIOVIE 2120 COLORADO AVENUE, SUITE 230 SANTA MONICA CA 90404
Business Address
Do Cuong V (Reporting) CIK: 0001477037 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39015 | Film No.: 21715929

Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations